Viveve Medical Inc. (VIVE)

[SooS416]

In this case for what the company is doing the split has not been harmful, the $4 price will come with added news and name change at the end of the month.

Look at the management team, read the 8k, see the audit firm used and tell me this doesn't look like a NASDAQ company.

Add to that 5am deals with mainly NASDAQ biotech companies and one can clearly put the pieces together, we are all just early to the party.

It will pick up and be a rager, just need to be patient as more show up to the fun.